$AXGN
Axogen, Inc. Stock $axgn

$axgn Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000155837020009978 Filed on August 07, 2020

Income Statement

Concept	2020 Q2	2019 Q2	2019 Q1
Revenue	$22.12M	$26.70M	$23.29M
YoY Change	-17.17%	29.72%	34.91%
Cost Of Revenue	$5.605M	$4.244M	$3.714M
YoY Change	32.07%	36.64%	20.98%
Gross Profit	$16.51M	$22.46M	$19.57M
YoY Change	-26.48%	28.49%	34.54%
Gross Profit Margin	74.66%	84.11%	84.05%
Selling, General & Admin	$20.69M	$25.85M	$25.64M
YoY Change	-19.94%	31.24%	49.65%
% of Gross Profit	125.33%	115.1%	130.98%
Research & Development	$4.071M	$4.282M	$4.139M
YoY Change	-4.93%	64.63%	100.92%
% of Gross Profit	24.66%	19.07%	21.15%
Depreciation & Amortization	$311.0K	$228.0K	$211.0K
YoY Change	36.4%	16.92%	5.5%
% of Gross Profit	1.88%	1.02%	1.08%
Operating Expenses	$24.77M	$30.13M	$29.77M
YoY Change	-17.8%	35.13%	55.23%
Operating Profit	-$8.254M	-$7.672M	-$10.20M
YoY Change	7.59%	59.24%	120.22%
Interest Expense	$31.00K	$11.00K	$700.0K
YoY Change	181.82%	-97.98%	-207.69%
% of Operating Profit
Other Income/Expense, Net	$149.0K	$649.0K	$699.0K
YoY Change	-77.04%	-124.87%
Pretax Income	-$8.110M	-$7.020M	-$9.500M
YoY Change	15.53%	-5.52%	68.44%
Income Tax
% Of Pretax Income
Net Earnings	-$8.105M	-$7.022M	-$9.504M
YoY Change	15.42%	-5.45%	68.39%
Net Earnings / Revenue	-36.65%	-26.3%	-40.82%
Basic Earnings Per Share	-$0.20
Diluted Earnings Per Share	-$0.20	-$179.2K	-$244.0K
COMMON SHARES
Basic Shares Outstanding	39.82M shares
Diluted Shares Outstanding	39.82M shares

Balance Sheet

Concept	2020 Q2	2019 Q2	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.30M	$103.1M	$107.8M
YoY Change	-3.69%	-22.83%	252.29%
Cash & Equivalents	$75.32M	$24.88M	$29.52M
Short-Term Investments	$24.00M	$78.20M	$84.30M
Other Short-Term Assets	$14.00M	$8.400M	$9.500M
YoY Change	66.67%	546.15%	578.57%
Inventory	$12.84M	$13.59M	$13.10M
Prepaid Expenses
Receivables	$14.05M	$16.29M	$15.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$140.2M	$141.3M	$145.6M
YoY Change	-0.75%	-9.95%	181.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.86M	$9.757M	$13.70M
YoY Change	154.77%	290.28%	470.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$29.73M	$15.31M	$14.90M
YoY Change	94.19%	325.31%	325.71%
TOTAL ASSETS
Total Short-Term Assets	$140.2M	$141.3M	$145.6M
Total Long-Term Assets	$29.73M	$15.31M	$14.90M
Total Assets	$170.0M	$156.6M	$160.5M
YoY Change	8.53%	-2.43%	190.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.887M	$5.681M	$7.400M
YoY Change	-31.58%	35.26%	124.24%
Accrued Expenses	$10.10M	$10.50M	$9.000M
YoY Change	-3.81%	87.5%	66.67%
Deferred Revenue	$14.00K	$19.00K	$24.00K
YoY Change	-26.32%	-29.63%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$1.553M	$1.832M	$0.00
YoY Change	-15.23%		-100.0%
Total Short-Term Liabilities	$14.02M	$16.23M	$16.50M
YoY Change	-13.65%	63.97%	5.77%
LONG-TERM LIABILITIES
Long-Term Debt	$32.00M	$2.381M	$0.00
YoY Change	1243.97%		-100.0%
Other Long-Term Liabilities	$1.660M	$2.400M	$3.200M
YoY Change	-30.83%	2300.0%	1500.0%
Total Long-Term Liabilities	$1.660M	$2.381M	$3.200M
YoY Change	-30.28%	2281.0%	-82.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.02M	$16.23M	$16.50M
Total Long-Term Liabilities	$1.660M	$2.381M	$3.200M
Total Liabilities	$50.20M	$18.64M	$19.70M
YoY Change	169.28%	86.43%	-41.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$196.2M	-$167.3M
YoY Change	17.28%
Common Stock	$315.9M	$305.2M
YoY Change	3.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$119.8M	$138.0M	$140.7M
YoY Change
Total Liabilities & Shareholders Equity	$170.0M	$156.6M	$160.5M
YoY Change	8.53%	-2.43%	190.76%

Cashflow Statement

Concept	2020 Q2	2019 Q2	2019 Q1
OPERATING ACTIVITIES
Net Income	-$8.105M	-$7.022M	-$9.504M
YoY Change	15.42%	-5.45%	68.39%
Depreciation, Depletion And Amortization	$311.0K	$228.0K	$211.0K
YoY Change	36.4%	16.92%	5.5%
Cash From Operating Activities	-$7.030M	-$5.810M	-$8.867M
YoY Change	21.0%	42.4%	51.83%
INVESTING ACTIVITIES
Capital Expenditures	-$8.260M	-$1.480M	$478.0K
YoY Change	458.11%	260.98%	-195.6%
Acquisitions
YoY Change
Other Investing Activities	$23.23M	$6.470M	$8.260M
YoY Change	259.04%
Cash From Investing Activities	$14.97M	$4.990M	$7.770M
YoY Change	200.0%	-1317.07%	-1654.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	36.10M	2.170M	325.0K
YoY Change	1563.59%	-97.98%	-18.75%
NET CHANGE
Cash From Operating Activities	-7.030M	-5.810M	-8.867M
Cash From Investing Activities	14.97M	4.990M	7.770M
Cash From Financing Activities	36.10M	2.170M	325.0K
Net Change In Cash	44.04M	1.350M	-772.0K
YoY Change	3162.22%	-98.69%	-87.0%
FREE CASH FLOW
Cash From Operating Activities	-$7.030M	-$5.810M	-$8.867M
Capital Expenditures	-$8.260M	-$1.480M	$478.0K
Free Cash Flow	$1.230M	-$4.330M	-$9.345M
YoY Change	-128.41%	17.98%	75.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39589755
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40020780
CY2020Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtCurrent
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtNoncurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36046
	dei	Entity Registrant Name EntityRegistrantName	Axogen, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1301878
	dei	Entity Address Address Line1 EntityAddressAddressLine1	13631 Progress Blvd., Suite 400
	dei	Entity Address City Or Town EntityAddressCityOrTown	Alachua
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Entity Central Index Key EntityCentralIndexKey	0000805928
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32615
	dei	City Area Code CityAreaCode	386
	dei	Local Phone Number LocalPhoneNumber	462-6800
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	AXGN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40084188
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75320000
CY2020Q2	axgn	Equity Derivative Liability Noncurrent EquityDerivativeLiabilityNoncurrent	176000
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1660000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1610000
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	us-gaap	Liabilities Liabilities	50201000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20880000
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	31960000
CY2020Q2	axgn	Debt Derivative Liability Noncurrent DebtDerivativeLiabilityNoncurrent	2387000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35724000
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	10610000
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	6000000
CY2020Q2	us-gaap	Short Term Investments ShortTermInvestments	24009000
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	60786000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	419000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1092000
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14049000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16944000
CY2020Q2	us-gaap	Inventory Net InventoryNet	12836000
CY2019Q4	us-gaap	Inventory Net InventoryNet	13861000
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3405000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1706000
CY2020Q2	us-gaap	Assets Current AssetsCurrent	140229000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	135021000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24858000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14887000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3138000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3133000
CY2020Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	76000
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	87000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1660000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1515000
CY2020Q2	us-gaap	Assets Assets	169961000
CY2019Q4	us-gaap	Assets Assets	154643000
CY2020Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12451000
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19130000
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1553000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1736000
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14000
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14000
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14018000
CY2019Q4	us-gaap	Liabilities Liabilities	22490000
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40020780
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39589755
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	400000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	396000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196158000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-179861000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	119760000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	132153000
CY2019Q2	us-gaap	Revenues Revenues	26701000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17875000
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	315518000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	311618000
CY2020Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	237000
CY2019Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	654000
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	548000
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1370000
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	30129000
	us-gaap	Costs And Expenses CostsAndExpenses	52719000
	us-gaap	Costs And Expenses CostsAndExpenses	59903000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8254000
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7672000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16763000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	169961000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	154643000
CY2020Q2	us-gaap	Revenues Revenues	22116000
	us-gaap	Revenues Revenues	46377000
	us-gaap	Revenues Revenues	49986000
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5605000
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4244000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10421000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7958000
CY2020Q2	us-gaap	Gross Profit GrossProfit	16511000
CY2019Q2	us-gaap	Gross Profit GrossProfit	22457000
	us-gaap	Gross Profit GrossProfit	35956000
	us-gaap	Gross Profit GrossProfit	42028000
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14290000
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18467000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	32128000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34901000
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4071000
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4282000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8685000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8421000
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6404000
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7380000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11906000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16581000
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	24765000
CY2020Q2	axgn	Interest Expense Net InterestExpenseNet	31000
CY2019Q2	axgn	Interest Expense Net InterestExpenseNet	11000
	axgn	Interest Expense Net InterestExpenseNet	62000
	axgn	Interest Expense Net InterestExpenseNet	25000
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-57000
CY2019Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-20000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	149000
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	649000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	466000
	us-gaap	Net Income Loss NetIncomeLoss	-16526000
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39823414
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39174712
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1349000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-8105000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39760602
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39055013
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-7023000
	us-gaap	Net Income Loss NetIncomeLoss	-16297000
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
	us-gaap	Net Income Loss NetIncomeLoss	-16297000
	us-gaap	Net Income Loss NetIncomeLoss	-16526000
	us-gaap	Depreciation Depreciation	618000
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.41
	us-gaap	Depreciation Depreciation	439000
	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	802000
	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	891000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	72000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35768000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	23519000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12764000
	axgn	Change In Net Unrealized Holding Gain Loss ChangeInNetUnrealizedHoldingGainLoss	602000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	35000000
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7820000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-115000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-159000
	us-gaap	Inventory Write Down InventoryWriteDown	1624000
	us-gaap	Inventory Write Down InventoryWriteDown	-95000
	axgn	Change In Net Unrealized Holding Gain Loss ChangeInNetUnrealizedHoldingGainLoss	141000
	us-gaap	Repayments Of Debt RepaymentsOfDebt	7820000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	350000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	658000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	8000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1784000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2515000
	us-gaap	Share Based Compensation ShareBasedCompensation	2778000
	us-gaap	Share Based Compensation ShareBasedCompensation	4989000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3010000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	805000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	600000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1510000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1699000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1312000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4212000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	816000
	us-gaap	Operating Lease Payments OperatingLeasePayments	915000
	us-gaap	Operating Lease Payments OperatingLeasePayments	846000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	2000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-12000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15081000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14678000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13183000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1685000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	22965000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	84142000
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	59883000
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	98871000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	216000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	280000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2498000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	44206000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	584000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41724000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30294000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85930000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30878000
	us-gaap	Interest Paid Net InterestPaidNet	23000
	us-gaap	Interest Paid Net InterestPaidNet	25000
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	617000
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	567000
	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	796000
	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	26000
	axgn	Embedded Derivative Associated With Long Term Debt EmbeddedDerivativeAssociatedWithLongTermDebt	2563000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	124194000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-8105000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2222000
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	17000
CY2020Q2	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	1466000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	119760000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	132153000
	us-gaap	Net Income Loss NetIncomeLoss	-16297000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2778000
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	658000
	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	1784000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	119760000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	140744000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-7023000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2674000
CY2019Q2	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	1565000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	137960000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	146982000
	us-gaap	Net Income Loss NetIncomeLoss	-16526000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4989000
	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	2515000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	137960000
	us-gaap	Basis Of Accounting BasisOfAccounting	<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">1.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">Basis of Presentation </b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The accompanying unaudited condensed consolidated financial statements include the accounts of the Company as of June 30, 2020 and December 31, 2019 and for the three and six-month periods ended June 30, 2020 and 2019. The Company’s condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X, and therefore, do not include all information and footnotes necessary for a fair presentation of consolidated financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2019, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended December 31, 2019, as amended on Form 10-K/A. The interim condensed consolidated financial statements are unaudited and in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results for the periods presented. Results for interim periods are not necessarily indicative of results for the full year. All intercompany accounts and transactions have been eliminated in consolidation. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The results of operations for the three and six-months ended June 30, 2020 are not necessarily indicative of the results to be expected for the full fiscal year due primarily to the impact of the continued uncertainty of general economic conditions that may impact our markets for the remainder of fiscal year 2020. Specifically, we are uncertain of the extent to which the Coronavirus Disease 2019 (“COVID-19<b style="font-weight:bold;">”) </b>pandemic will affect our sales channels, supply chain, manufacturing, distribution capabilities, clinical trials, employee availability and productivity and capital expenditures. The Company’s access to healthcare facilities has improved each month, although restrictions remain and supporting customers remotely continues to be an important learned capability. There can be no assurances that resurgences of COVID-19 will not affect our future results.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The presentation of long-term obligations and contract liabilities were condensed on the Company’s balance sheet to conform to current year presentation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p>
CY2018Q4	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	15321000
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18000
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	42000
CY2019Q2	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	16285000
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	19000
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	29000
	axgn	Increase Decrease In Contract Receivable IncreaseDecreaseInContractReceivable	964000
	axgn	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	1000
	axgn	Increase Decrease In Contract With Customer Liability Noncurrent IncreaseDecreaseInContractWithCustomerLiabilityNoncurrent	-13000
CY2019Q4	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	16944000
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14000
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000
CY2020Q2	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	14049000
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14000
CY2020Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000
	axgn	Increase Decrease In Contract Receivable IncreaseDecreaseInContractReceivable	-2895000
	axgn	Increase Decrease In Contract With Customer Liability Noncurrent IncreaseDecreaseInContractWithCustomerLiabilityNoncurrent	-6000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2459220
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1712834
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">3.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><b style="font-weight:bold;">Recently Issued Standards to be Adopted </b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The Company’s management has reviewed and considered all other recent accounting pronouncements and believe there are none that could potentially have a material impact on the Company’s consolidated financial condition, results of operations, or disclosures.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p>
CY2020Q2	axgn	Prepaid Events PrepaidEvents	448000
CY2020Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9101000
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10403000
CY2020Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	771000
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	730000
CY2020Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2964000
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2728000
CY2020Q2	us-gaap	Inventory Net InventoryNet	12836000
CY2019Q4	us-gaap	Inventory Net InventoryNet	13861000
	us-gaap	Inventory Write Down InventoryWriteDown	1624000
	us-gaap	Inventory Write Down InventoryWriteDown	-95000
CY2020Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2563000
CY2020Q2	us-gaap	Prepaid Insurance PrepaidInsurance	1077000
CY2019Q4	us-gaap	Insurance Receivable For Malpractice Current InsuranceReceivableForMalpracticeCurrent	98000
CY2019Q4	axgn	Stock Option Receivable StockOptionReceivable	244000
CY2020Q2	us-gaap	Insurance Receivable For Malpractice Current InsuranceReceivableForMalpracticeCurrent	21000
CY2019Q4	axgn	Prepaid Events PrepaidEvents	110000
CY2020Q2	us-gaap	Prepaid Advertising PrepaidAdvertising	417000
CY2019Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	227000
CY2020Q2	axgn	Prepaid Software License PrepaidSoftwareLicense	239000
CY2019Q4	axgn	Prepaid Software License PrepaidSoftwareLicense	207000
CY2020Q2	axgn	Prepaid Professional Fees PrepaidProfessionalFees	684000
CY2019Q4	axgn	Prepaid Professional Fees PrepaidProfessionalFees	433000
CY2020Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	519000
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	387000
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3405000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1706000
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29240000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18651000
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4382000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3764000
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24858000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14887000
CY2020Q2	us-gaap	Depreciation Depreciation	311000
CY2019Q2	us-gaap	Depreciation Depreciation	228000
	us-gaap	Depreciation Depreciation	618000
	us-gaap	Depreciation Depreciation	439000
CY2020Q2	us-gaap	Escrow Deposits Related To Property Sales EscrowDepositsRelatedToPropertySales	5828000
CY2020Q2	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	1218000
CY2020Q2	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	4610000
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1660000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1515000
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36000
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	72000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56000
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3887000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8262000
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2461000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3237000
CY2020Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6103000
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7631000
CY2020Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12451000
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19130000
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2222000
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2674000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2778000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4989000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M17D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M3D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5952
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5361
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0038
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0259
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1565000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3138000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3133000
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1536000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1719000
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1629000
CY2020Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	6000
CY2019Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	6000
CY2020Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000
CY2019Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	491000
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	475000
CY2020Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10000
CY2019Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000
CY2020Q2	us-gaap	Variable Lease Cost VariableLeaseCost	51000
CY2019Q2	us-gaap	Variable Lease Cost VariableLeaseCost	14000
CY2020Q2	us-gaap	Lease Cost LeaseCost	559000
CY2019Q2	us-gaap	Lease Cost LeaseCost	501000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	11000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	11000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000
	us-gaap	Operating Lease Cost OperatingLeaseCost	976000
	us-gaap	Operating Lease Cost OperatingLeaseCost	964000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	16000
	us-gaap	Variable Lease Cost VariableLeaseCost	61000
	us-gaap	Variable Lease Cost VariableLeaseCost	15000
	us-gaap	Lease Cost LeaseCost	1060000
	us-gaap	Lease Cost LeaseCost	1008000
CY2020Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	76000
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	87000
CY2020Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000
CY2020Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	22000
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	30000
CY2020Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	19000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3525000
CY2020Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	10000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2539000
CY2020Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	3000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2601000
CY2020Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	1000
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	915000
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	949000
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	15000
CY2020Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2019Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2019Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2020Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0728
CY2019Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0709
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0600
CY2019Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0628
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	931000
CY2020Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	10000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3007000
CY2020Q2	axgn	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	2666000
CY2020Q2	axgn	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	26352000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	41621000
CY2020Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	43000
CY2020Q2	axgn	Lessee Operating Lease Liability Future Payments Amount LesseeOperatingLeaseLiabilityFuturePaymentsAmount	38246000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	210000
CY2020Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	4000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3165000
CY2020Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	39000
	axgn	Term Of Agreement TermOfAgreement	P5Y
CY2018Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	70000
CY2018Q3	us-gaap	Area Of Land AreaOfLand	8.6
CY2018Q3	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	731000
CY2020Q2	axgn	License Fee Amount LicenseFeeAmount	279000
CY2019Q2	axgn	License Fee Amount LicenseFeeAmount	574000
	axgn	License Fee Amount LicenseFeeAmount	739000
	axgn	License Fee Amount LicenseFeeAmount	1057000
CY2020Q2	axgn	Payment For Service Fees PaymentForServiceFees	107000
CY2019Q2	axgn	Payment For Service Fees PaymentForServiceFees	309000
	axgn	Payment For Service Fees PaymentForServiceFees	623000
	axgn	Payment For Service Fees PaymentForServiceFees	546000
CY2018Q3	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	4300000
CY2019Q3	axgn	Estimated Cost Relating To Design Build Agreement EstimatedCostRelatingToDesignBuildAgreement	29000000
CY2019Q3	axgn	Additional Costs Associated With Design Build Agreement AdditionalCostsAssociatedWithDesignBuildAgreement	13000000
CY2020Q2	axgn	Estimated Cost Relating To Design Build Agreement EstimatedCostRelatingToDesignBuildAgreement	8096000
CY2020Q2	axgn	Construction In Progress With Design Build Agreement ConstructionInProgressWithDesignBuildAgreement	14162000
CY2019Q1	axgn	Threshold Period For Not Filing Response To Complaint ThresholdPeriodForNotFilingResponseToComplaint	P30D
	axgn	Defined Contribution Plan Minimum Age Limit For Eligibility To Participate In Plan DefinedContributionPlanMinimumAgeLimitForEligibilityToParticipateInPlan	18

Files In Submission

Name	View Source	Status
0001558370-20-009978-index-headers.html	Edgar Link	pending
0001558370-20-009978-index.html	Edgar Link	pending
0001558370-20-009978.txt	Edgar Link	pending
0001558370-20-009978-xbrl.zip	Edgar Link	pending
axgn-20200630.xsd	Edgar Link	pending
axgn-20200630ex3116d0d7b.htm	Edgar Link	pending
axgn-20200630ex312de3871.htm	Edgar Link	pending
axgn-20200630x10q.htm	Edgar Link	pending
axgn-20200630x10q_htm.xml	Edgar Link	completed
axgn-20200630xex32.htm	Edgar Link	pending
axgn-20200630_cal.xml	Edgar Link	unprocessable
axgn-20200630_def.xml	Edgar Link	unprocessable
axgn-20200630_lab.xml	Edgar Link	unprocessable
axgn-20200630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AXGN
Axogen, Inc. Stock $axgn

2020 Q2 Form 10-Q Financial Statement

#000155837020009978 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN Axogen, Inc. Stock $axgn

2020 Q2 Form 10-Q Financial Statement

#000155837020009978 Filed on August 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN
Axogen, Inc. Stock $axgn